Nanobiotix
NBTX
5 hedge funds and large institutions have $12.2M invested in Nanobiotix in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0.04% less ownership
Funds ownership: 9.97% → 9.93% (-0.04%)
8% less capital invested
Capital invested by funds: $13.3M → $12.2M (-$1.06M)
17% less funds holding
Funds holding: 6 → 5 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$49K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $4.91M | – | – | – |
|
|
PA
2
Perceptive Advisors
New York
| $3.75M | – | – | – |
|
|
AG
3
Artal Group
Luxembourg
| $3.54M | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $11K | +$8 | +2 | +0.1% |
|
|
AWM
5
Activest Wealth Management
Aventure,
Florida
| $1K | – | – | – |
|
|
WP
6
Woodline Partners
San Francisco,
California
| – | -$49K | -13,009 | Closed |
|
NBTX Hedge Fund Activity: Q3 2022 in Review
5 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q3 2022, worth a combined $12.2M — down 8% from $13.3M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NBTX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $8. The largest seller was Woodline Partners, exiting entirely with an estimated $49K sold.
- 5 institutional investors held Nanobiotix (NBTX) as of Q3 2022, down from 6 in Q2 2022.
- Funds reported $12.2M of Nanobiotix stock for Q3 2022, down 8% quarter-over-quarter.
- 0 funds opened new Nanobiotix positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest Nanobiotix buyer in Q3 2022 was UBS Group, an estimated $8 added.
- The largest Nanobiotix seller in Q3 2022 was Woodline Partners, an estimated $49K sold.
Based on aggregated 13F filings for Q3 2022.